Bibliografia UJ CM

1/3
Ralf Gold, Gavin Giovannoni, Krzysztof Selmaj, Eva Havrdova, Xavier Montalban, Ernst-Wilhelm Radue, Dusan Stefoski, Randy Robinson, Katherine Riester, Jitesh Rana, Jacob Elkins, Gilmore O'Neill, SELECT study investigators.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.
Lancet
2013 : Vol. 381, nr 9884, s. 2167-2175, il., bibliogr. 29 poz., sum.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 39.207
2/3
Jeffrey A. Cohen, Alasdair Coles, Douglas L. Arnold, Christian Confavreux, Edward J. Fox, Hans-Peter Hartung, Eva Havrdova, Krzysztof W. Selmaj, Howard L. Weiner, Elizabeth Fisher, Vesna V. Brinar, Gavin Giovannoni, Miroslav Stojanovic, Bella I. Ertik, Stephen L. Lake, David H. Margolin, Michael A. Panzara, D. Alastair S. Compston, CARE-MS I investigators.
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
Lancet
2012 : Vol. 380, nr 9856, s. 1819-1828
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 39.060
3/3
Gavin Giovannoni, Giancarlo Comi, Stuart Cook, Kottil Rammohan, Peter Rieckmann, Per Soelberg Sorensen,, Patrick Vermersch, Peter Chang, Anthony Hamlett, Bruno Musch, Steven J. Greenberg, CLARITY Study Group.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
New England Journal of Medicine
2010 : Vol. 362, nr 5, s. 416-426, il., bibliogr. 19 poz., abstr.
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 53.486
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ